Research Support, Non-U.S. Gov't
- Therapeutic potential of an AcHERV-HPV L1 DNA vaccine
-
Hee-Jung Lee , Jong Kwang Yoon , Yoonki Heo , Hansam Cho , Yeondong Cho , Yongdae Gwon , Kang Chang Kim , Jiwon Choi , Jae Sung Lee , Yu-Kyoung Oh , Young Bong Kim
-
J. Microbiol. 2015;53(6):415-420. Published online May 30, 2015
-
DOI: https://doi.org/10.1007/s12275-015-5150-0
-
-
12
View
-
0
Download
-
8
Citations
-
Abstract
- Cervical cancer is strongly associated with chronic human
papillomavirus infections, among which HPV16 is the most
common. Two commercial HPV vaccines, Gardasil and
Cervarix are effective for preventing HPV infection, but cannot
be used to treat existing HPV infections. Previously, we
developed a human endogenous retrovirus (HERV)-enveloped
recombinant baculovirus capable of delivering the L1
genes of HPV types 16, 18, and 58 (AcHERV-HP16/18/58L1,
AcHERV-HPV). Intramuscular administration of AcHERVHPV
vaccines induced a strong cellular immune response
as well as a humoral immune response. In this study, to examine
the therapeutic effect of AcHERV-HPV in a mouse
model, we established an HPV16 L1 expressing tumor cell
line. Compared to Cervarix, immunization with AcHERVHPV
greatly enhanced HPV16 L1-specific cytotoxic T lymphocytes
(CTL) in C57BL/6 mice. Although vaccination
could not remove preexisting tumors, strong CTL activity
retarded the growth of inoculated tumor cells. These results
indicate that AcHERV-HPV could serve as a potential therapeutic
DNA vaccine against concurrent infection with HPV
16, 18, and 58.
- Anti-tumor Activity of the Fruitbody Extract of Basidiomycete, Phellinus linteus
-
Jong-Soon Lim , Seung-Hyung Kim , Jin-Seo Park , Jeong-Youl Choi , Seong Joo Park , Kwang-Soo Shin
-
J. Microbiol. 2001;39(2):121-125.
-
-
-
Abstract
- Methanol extract prepared from the fruitbody of Phellinus linteus (EPL) showed anti-tumor and immuno-stimulating activities. The invasion activity of B16-F10 melanoma cells through a reconstituted basement membrane to the collagen-coated lower surface of the filters was inhibited about 67% by EPL (100 ug/ml). Also, EPL inhibited the expression of the mRNA for MMP-2 and MMP-9. In vivo treatment of C57BL/6 mice (150 mg/kg) with EPL for 14 days, the pulmonary colonization was found to be inhibited about 75%. Using reverse transcriptionpolymerase chain reaction (RT-PCR) analysis, we found that cytokine IL-12 and INF-[gamma] genes were induced by EPL. Furthermore, EPL stimulated the proliferation of CD4^+ (33.5%) and CD8^+ (17.7%) in mouse splenocytes.